Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Trapp

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
EJNMMI Research|June 23, 2026
Outcome after primary directed radiotherapy in predominantly PSMA-PET/CT-staged patients with metastatic prostate cancerChristian Trapp, Sarah Frederike Brose, Michael Keilholz, et al.
Clinical and Translational Radiation Oncology|January 6, 2023
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapyMinglun Li, Yourong Fan, Christian Trapp, et al.
Clinical and Translational Radiation Oncology|October 9, 2024
Physician reported toxicities and patient reported quality of life of transperineal ultrasound-guided radiotherapy of prostate cancerJing Ma, Paul Rogowski, Christian Trapp, et al.
Radiation Oncology (London, England)|June 14, 2025
Evaluating large language models as an educational tool for meningioma patients: patient and clinician perspectivesDiana-Coralia Dehelean, Sebastian H Maier, Alev Altay-Langguth, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 10, 2025
Patient- and clinician-based evaluation of large language models for patient education in prostate cancer radiotherapyChristian Trapp, Nina Schmidt-Hegemann, Michael Keilholz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2021
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomyPaul Rogowski, Christian Trapp, Rieke von Bestenbostel, et al.
Theranostics|June 8, 2022
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databasesRun Shi, Xin Wang, Yang Wu, et al.
Frontiers in Oncology|July 8, 2021
Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial DesignAlexander Kretschmer, Johanna Milow, Chukwuka Eze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer PatientsChristian Trapp, Dmytro Oliinyk, Paul Rogowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOGErik F Moar, Michael Keilholz, Gabriel T Sheikh, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
EJNMMI Research|June 23, 2026
Outcome after primary directed radiotherapy in predominantly PSMA-PET/CT-staged patients with metastatic prostate cancerChristian Trapp, Sarah Frederike Brose, Michael Keilholz, et al.
Clinical and Translational Radiation Oncology|January 6, 2023
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapyMinglun Li, Yourong Fan, Christian Trapp, et al.
Clinical and Translational Radiation Oncology|October 9, 2024
Physician reported toxicities and patient reported quality of life of transperineal ultrasound-guided radiotherapy of prostate cancerJing Ma, Paul Rogowski, Christian Trapp, et al.
Radiation Oncology (London, England)|June 14, 2025
Evaluating large language models as an educational tool for meningioma patients: patient and clinician perspectivesDiana-Coralia Dehelean, Sebastian H Maier, Alev Altay-Langguth, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 10, 2025
Patient- and clinician-based evaluation of large language models for patient education in prostate cancer radiotherapyChristian Trapp, Nina Schmidt-Hegemann, Michael Keilholz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2021
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomyPaul Rogowski, Christian Trapp, Rieke von Bestenbostel, et al.
Theranostics|June 8, 2022
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databasesRun Shi, Xin Wang, Yang Wu, et al.
Frontiers in Oncology|July 8, 2021
Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial DesignAlexander Kretschmer, Johanna Milow, Chukwuka Eze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer PatientsChristian Trapp, Dmytro Oliinyk, Paul Rogowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOGErik F Moar, Michael Keilholz, Gabriel T Sheikh, et al.
Pageof 3